VOR Projected Dividend Yield
Vor Biopharma Inc ( NASDAQ : VOR )Vor Biopharma Inc. is a clinical-stage cell and genome engineering therapy company. Co. is engaged in combining a novel patient engineering approach with targeted therapies to provide solutions for patients suffering from hematological malignancies. Its proprietary platform leverages expertise in hematopoietic stem cell (HSC) biology, genome engineering and targeted therapy development to genetically modify HSCs to remove surface targets expressed by cancer cells. Co.'s lead engineered hematopoietic stem cells (eHSC) product candidate include tremtelectogene empogeditemcel (trem-cel), for the treatment for acute myeloid leukemia (AML) and other blood cancers. 21 YEAR PERFORMANCE RESULTS |
VOR Dividend History Detail VOR Dividend News VOR Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |